Recombinant Fusobacterium necrophorum leukotoxin vaccine...

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S320100, C435S252300, C435S071100, C435S069300, C435S069100, C530S350000, C536S023700, C536S023100, C424S236100, C424S234100, C424S184100

Reexamination Certificate

active

07449310

ABSTRACT:
TheF. necrophorum geneexpressing leukotoxin was sequenced and cloned. The leukotoxin open reading frame (lktA) is part of a multi-gene operon containing 9,726 bp, and encoding a protein containing 3,241 amino acids with an overall molecular weight of 335,956 daltons. The protein encoded by the gene was truncated into five polypeptides having overlapping regions by truncating the full length gene into five different sections and amplifying, expressing, and recovering the protein encoded by each of these sections. Additionally, a region upstream of the gene was sequenced and the polypeptide encoded by that nucleotide sequence was purified and isolated. These polypeptides along with the full length protein are then tested to determine their immunogenicity and protective immunity in comparison to the efficacy of immunization conferred by inactivated native leukotoxin inF. necrophorumculture supernatant.

REFERENCES:
patent: 4152415 (1979-05-01), Harris et al.
patent: 4203968 (1980-05-01), Harris et al.
patent: 4919929 (1990-04-01), Beck
patent: 5455034 (1995-10-01), Nagaraja et al.
patent: 5804190 (1998-09-01), Struck et al.
patent: 5861162 (1999-01-01), Nagaraja et al.
Bowie et al. Science, vol. 247: 1990; p. 1306; p. 1308.
Houghten et al. (Vaccines, 1986, Edited by Fred Brown: Cold Spring Harbor Laboratory).
Abe et al.;Fusobacterium necrophoruminfection in mice as a model for the study of liver abscess formation and induction of immunity; (1976); Infect. Immun. 13:1473-1478.
Abe et al.; Immunization of Mice AgainstFusobacterium necrophoruminfection by Parenteral or Oral Administration of Vaccine; (1978); Am J. Vet Res.; 39:115-118.
Berson, G.; Silver staining of proteins in polyacrylamide gels: increased sensitivity by a blue toning, (1983); Anal. Biochem. 134:230-234.
Cameron et al.; Antibody Response to and Immunity Induced by Corynebacterium Pyogenes Vaccine; Onderstepoort J. vet. Res. 43 (3), 97-104 (1976).
Cameron et al.; Failure to INduce in Rabbits Effective Immunity to a Mixed Infection ofFusobacterium mectrophorumandCorynebacterium pyogeneswith a Combined Bacterin; Onderstepoort J. vet. Res. 44 (4), 253-256 (1977).
Conion et al.; Evaluation of experimentally inducedFusobacterium necrophoruminfections in mice; (1977); Infect. Immun. 15:510-517.
Coyle-Dennis, et al.; Biological and Biochemical Characteristics ofFusobacterium necrophorumLeukocidin; Am. J. Vet Res. (1978); 39:1790-1793.
Coyle-Dennis, et al.; Correlation between leukocidin production and virulence of two isolates ofFusobacterium necrophorum. (1979) Am. J. Vet Res. 40:274-276.
Emery et al.; Generation of immunity againstFusobacterium necrophorumin mice inoculated with extracts containing leukocidin; (1986) Vet. Microbiol. 12:255-268.
Emery et al.; Biochemical and functional properties of a leukocidin produced by several strains ofFusobacterium necrophorum; (1984); Aus. Vet. J.; 61:382-385.
Emery et al.; Studies on the purification of the leukocidin ofFusobacterium necrophorumand its neutralization by specific antisera; (1986); Vet. Microbiol. 11:357-372.
Emery et al.; Virulence determinants ofFusobacterium necrophorumand their prophylactic potential in animals. In: Stewart, D.J., Peterson, J.E., McKern, N.M. and Emery D.L. (eds), Foot rot in reminants. Proceedings of a workshop, Melbourne (CSIRO Division of animal health, Australian wool corporation, Australia), 267-274.
Garcia et al.; Biological characterization ofFusobacterium necrophorumcell fractions in preparation for toxin and immunization studies; (1975); Infect. Immun. 11:606-616.
Garcia et al; Results of a preliminary trial with sphaerophorus necrophorus toxoids to control liver abscesses in feedlot cattle; Can. J. Comp. Med., (1974) 38:222-226.
Garcia, et al.; Intraperitoneal immunization against necrobacillosis in experimental animals; (1978) Can. J. Comp. Med. 42:121-127.
Hunter, et al.; Failure of an Actinomyces Pyogenes Vaccine to Protect Sheep Against an Intravenous Challenge; Onderstepoort J. vet. Res., 57, 239-241 (1990).
Langworth, B.F.;Fusobacterium necrophorum; (1977); Bacteriol. Rev. 41:373-390.
Nagaraja et al.; Liver abscesses in feedlot cattle: A review; (1998); J. Anim. Sci. 76:287-298.
Narayanan et al.; Cloning, sequencing and expression of the leukotoxin gene fromFusobacterium necrophorum; Infect. and Immun.; Spet. 2001, vol. 69, No. 9, p. 5447-5455.
Rowe et al.; Microtechnique for most-probable-number analysis; (1977); Appl. Environ. Microbiol. 33:675-680.
Saginala et al.; Effect ofFusobacterium necrophorumleukotoxoid vaccine on susceptibility to experimentally induced liver abscesses in cattle; (1997); J. Anim. Sci. 75:1160-1166.
Saginala et al.; The serum neutralizing antibody response in cattle toFusobacterium necrophorumleukotoxoid and possible protection against experimentally induced hepatic abscesses; (1996a); Vet. Res. Comm., 20:493-504.
Saginala et al.; The serum neutralizing antibody response and protection against experimentally induced liver abscesses in steers vaccinated withFusobacterium necrophorum; (1996b); Am. J. Vet. Res. 57:483-488.
Smith, et al.; Pathogenicity ofFusobacterium necrophorumstrains from man and animals; (1993); Epidemiol. Infect. 110:499-506.
Smith, et al.; Necrobacillus and immunity in mice; (1989); Epidemiol. Infect. 103:211-215.
Tan et al.; Selective anumeration ofFusobacterium necrophorumfrom the bovine rumen; (1994b); Appl. Environ. Microbiol. 60:1387-1389.
Tan et al.;Fusobacterium necrophoruminfections: virulence factors, pathogenic mechanism and control measures; (1996); Vet. Res. Comm. 20:113-140.
Tan et al.; Biological and biochemical characterization ofFusobacterium necrophorumleukotoxin; (1994c); Am. J. Vet. Res. 55:515.
Tan et al.; Purification and quantification ofFusobacterium necrophorumleukotoxin using monoclonal antibodies; (1994d); Vet. Microbiol 42:121-133.
Warner et al.; Passive Hemmagglutination Test for Determining the Immune Response of Rabbits to Sphaerophorus necrophorus of bovine hepatic abscess origin; (1974); Am. J. Vet. Res. 35:551-554.
Nagaraja et al., The Compendium, Sep. 1996, pp. S230-241.
Nagaraja et al., The Compendium, Oct. 1996; pp. S264-273.
Gillis et al.; Evaluation of Primary Rumen Epithelial Cell Culture Technique in Sheep, Fed. Proc. 11:LB210.
Zeller, U.P., Toxin Production by Corynebacterium pyogenes, toxin storage, antibody titres in blood and milk serum samples from healthy and mastitic cows. CAB Accession No. 792236623 (1978).
Vladutiu, O. et al.; Immunization of swine against corynebacterial osteoarthropathy; CAB Accession No. 792237402; (1975/1976).
Funk et al.; Identification and partial characterization of an actinomyces pyogenes hemolysin; Vet. Micro., 50 (1996) 129-142.
Morrison et al.; Identification of Actinomyces (Corynebacterium) pyogenes with the API 20 Strep System, J. Clinical Microbiology; vol. 26, No. 9, 1988, pp. 1865-1866.
Narayanan et al.; Biochemical and biological characterizations and ribotyping of actinomyces pyogenes and actinomyces pyogenes-like organisms from liver abscesses in cattle; Veterinary Microbiology, 61 (1998), pp. 289-303.
Billington, et al.; Molecular characterization of the pore-forming toxin, pyolysin, a major virulence determinant; Veterinary Microbiology, 82 (2001), 261-274.
Billington, et al. The Aracanobacterium (Actinomyces) pyogenes Hemolysin, Pyolysin, is a novel member of the Thiol-Activated Cytolysin Family; J. Bacteriology, Oct. 1997, p. 6100-6106.
Billington, et al.; Tyiol-activated cytolysins: structure, function and role in pathogenesis; FEMS Microbiology Letters 182 (2000, 197-205.
Jost et al.; An arcanobacterium (actinomyces) pyogenes mutant deficient in production of the pore-forming cytolysin pyolysin has reduced virulence; Infection and Immunity, Apr. 1999, p. 1723-1728.
Koromyslov, G.F., Vaccine for prevention of necrobacteriosis in cattle; SU 1835295 (Abstract).
Manual of Clinical Microbiology (3rd Ed.),Culture Media, p. 975.
Quinones, Sowerby, C.A., New vaccine against bovine keratoconjunctivitis; CAB Accession No. 792237182 (1978).
Testing of Combined Fusobacterium Necrophorum Leukotoxoid and Ac

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant Fusobacterium necrophorum leukotoxin vaccine... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant Fusobacterium necrophorum leukotoxin vaccine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant Fusobacterium necrophorum leukotoxin vaccine... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4050594

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.